CN102920833A - Externally applied medicine for curing prostatitis - Google Patents
Externally applied medicine for curing prostatitis Download PDFInfo
- Publication number
- CN102920833A CN102920833A CN 201210435474 CN201210435474A CN102920833A CN 102920833 A CN102920833 A CN 102920833A CN 201210435474 CN201210435474 CN 201210435474 CN 201210435474 A CN201210435474 A CN 201210435474A CN 102920833 A CN102920833 A CN 102920833A
- Authority
- CN
- China
- Prior art keywords
- group
- crude drug
- radix
- medicine
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses externally applied medicine for curing prostatitis. The medicine is composed of a first group of active pharmaceutical ingredients (APIs) and a second group of APIs, wherein the first group of APIs comprises cassia twig, licorice and the like; and the second group of APIs comprises amur cork tree bark and the like. The medicine comprises more than thirty medicinal materials such as red flower and the licorice, producing time is long, and properties of the medicine are fully induced through a fermentation process, so that penetration of the medicine is strengthened; the medicine is soaked by rice wine alcohol which can induce efficacy as a medicinal inducer in itself; and gauze is soaked by liquid medicine, ointment is matched for use, the efficacy is further strengthened, curing time is shortened, and properties of the ointment are fully played. The reactions of users are obvious during usage, effects of the medicine are remarkable, and the medicine can eliminate diseases and radically treat sickness through reasonable use.
Description
Technical field
The present invention relates to a kind of medicine preparation, particularly relate to a kind of prostatitic application compress for the treatment of.
Background technology
Prostatitis is the crisscross pathological change that the prostatic inflammation that causes of Various Complex reason and inducement, immunity, neuroendocrine participate in, and causes the disease take urethral stimulant symptom and chronic pelvic pain as main clinical manifestation.Perineum, suprapubic region, inguinal region, genitals pain discomfort can appear in prostatitic clinical manifestation variation; Urethral symptom has burn feeling, urgent micturition, frequent micturition, the pain of urinating when urinating, can be with terminal hematuria or the urethra purulent secretion of urinating; Actute infection can be with aversion to cold, heating, the General Symptoms such as weak.Prostatitis is one of commonly encountered diseases of adult male.Although it is not a kind of direct life-threatening disease, has a strong impact on Quality of Life.Prostatitis patient accounts for Urologic Surgery Clinic patient's 8%~25%, approximately has 50% male can be subject to prostatitic impact in certain period in life.Prostatitis can affect the adult male of all age group, and the adult male prevalence of the right side of fifty is higher.The prostatitis morbidity also may be relevant with season, diet, sexual activity, inflammation of genitourinary tracts, benign prostatic hyperplasia or lower urinary tract syndrome, occupation, socioeconomics and psychologic factors etc.
Present Therapeutic Method mainly adopts takes the antibiotic medicine treatment.But antibiotic use may bring harm, harm one: use in a large number antibiotic can bring stronger toxic and side effects, directly injure health, especially to child's audition; Harm two: antibiotic has been used many and can have been made antibacterial produce drug resistance, make the antibiotic medicine deleterious, even invalid; Harm three: antibiotic is used too much, can kill in a large number normal bacteria in the body, thereby cause dysbacteriosis, can cause the shortage of some vitamin, and passive protective physical fitness is descended.Even allow pathogenic bacterium take advantage of a weak point, can cause people's death.
Summary of the invention
One object of the present invention is to provide a kind of significant reaction, effect of drugs, the simple outstanding prostatitic application compress for the treatment of of processing.
For achieving the above object, technical solution of the present invention is:
A kind ofly treat prostatitic application compress, it is comprised of first group of crude drug and second group of crude drug;
Described first group of crude drug comprises the crude drug of following weight portion: Ramulus Cinnamomi 10-15 part, Radix Glycyrrhizae 5-15 part, Radix Rehmanniae Preparata 15-20 part, Flos Carthami 8-15 part, Rhizoma Chuanxiong 10-15 part, Radix Angelicae Sinensis 18-25 part, Radix Paeoniae Rubra 12-20 part, Cortex Eucommiae 10-15 part, Caulis Clematidis Finetianae 20-25 part, GUIGENG 10-20 part, Lignum Sappan 15-30 part, Cortex Cinnamomi 15-20 part, Fructus Psoraleae 15-25 part, Semen Cuscutae 10-15 part, Radix Angelicae Dahuricae 15-20 part;
Described second group of crude drug comprises the crude drug of following weight portion: Cortex Phellodendri 10-15 part, Radix Notoginseng 8-15 part, Radix Angelicae Sinensis 20-25 part, Flos Carthami 10-15 part, Fructus Chaenomelis 20-30 part, Pyritum 8-15 part, Rhizoma Drynariae 10-15 part, Radix Achyranthis Bidentatae 10-15 part, Cortex cercis chinensis 20-30 part, Fructus Aurantii 20-30 part, Cortex Cinnamomi 10-15 part, Radix Rehmanniae Preparata 15-20 part, Fructus Psoraleae 15-20 part, Semen Cuscutae 10-15 part, Radix Dipsaci 10-15 part, Radix Clematidis 8-15 part.
A kind of preparation method for the treatment of the prostatitis application compress, it may further comprise the steps:
Step 1, get first group of crude drug, with first group of crude drug with ferment after rice wine mixes by the 1:8-12 weight ratio, more than fermentation half a year, obtain first group of raw material medicinal liquid;
Step 2, first group of raw material medicinal liquid after step 1 fermentation filtered, obtain first group of crude drug filtrate;
Step 3, first group of crude drug filtrate getting 85%-95% add second group of crude drug, first group of crude drug filtrate mixes by the weight ratio of 1:9-16 with second group of crude drug, fermentation 5-15 day, presents the mud shape, add binding agent and carry out adhesive formulations, make ointment;
Step 4, the hospital gauze of well cutting is put into the remaining first group of crude drug filtrate of step 2 soak, soak and 8-12 day make absorbent gauze.
The fermentation temperature of described step 1 is 40-50 ℃.
Binding agent in the described step 3 is dextrin or Fructus Hordei Germinatus.
A kind of using method for the treatment of the prostatitis application compress is specially: gets the absorbent gauze that soaks, spreads ointment, be used for umbilicus and lower abdomen place, and to carrying out 35-45 ℃ heated at constant temperature herein, once a day, every next hour.
In the such scheme, the Radix Paeoniae Rubra clearing away heat and cooling blood, therefore stasis-dispelling and pain-killing is the energy removing fire from the liver; The Rhizoma Chuanxiong promoting QI circulation for relieving depression, expelling wind and dampness, promoting blood circulation and stopping pain; The Flos Carthami promoting blood circulation to restore menstrual flow, regulating blood flow to alleviate pains has blood circulation promoting and blood stasis dispelling concurrently, dredge the meridian passage; Fructus Aurantii promoting the circulation of QI to relieve pain, expectorant can stagnate Ramulus Cinnamomi expelling pathogenic factors from muscles by diaphoresis, expelling wind and cold, warming YANG pain relieving, promote the circulation of qi and water by dispelling the stagnated QI except painful abdominal mass; Radix Glycyrrhizae is invigorating the spleen and replenishing QI, mediation thread medicine, relieving spasm to stop pain; Radix Rehmanniae Preparata has the YIN nourishing of enriching blood effect, removing dampness to relieve pain; Chinese angelica blood supplementing is invigorated blood circulation, the energy dispersing cold for relieving pain of holding concurrently again; Cortex Eucommiae sweet in the mouth, warm in nature.The energy invigorating the liver and kidney, bone and muscle strengthening, antiabortive; The Caulis Clematidis Finetianae expelling wind and removing dampness, promoting blood circulation and detoxication; The Lignum Sappan blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain; It is supporing yang that Cortex Cinnamomi is mended fire, let the fire back to its origin, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow, Fructus Psoraleae warming the kidney to activate YANG, improving inspiration by invigorating kidney-QI, antidiarrheal; The Semen Cuscutae nourishing the liver and kidney, the controlling nocturnal emission with astringent drugs reducing urination, antiabortive, make eye bright antidiarrheal; Radix Angelicae Dahuricae expelling pathogenic wind from the body surface, dispersing cold for relieving pain has powerful dehumidifying effect concurrently; The Radix Clematidis expelling wind and removing dampness can removing obstruction in the collateral to relieve pain, and is hot loose and lead to, impatient being apt to away, and the twelve regular channels that passes through is walked and is not kept; Cortex Phellodendri nature and flavor bitter cold has heat clearing and damp drying, and pathogenic fire purging is except steaming, and the effect of skin ulcer is treated in detoxifcation.The hemostasis of Radix Notoginseng dissipating blood stasis, the effect of subduing swelling and relieving pain; Pyritum is promoting blood circulation, removing blood stasis and relieving pain medicine commonly used; Fructus Chaenomelis has preferably relaxing muscles and tendons and activating QI and blood in the collateral effect, and the energy removing dampness, and by the dispelling the wind and dampness pathogens arthralgia pain is commonly used, muscle arteries and veins contracture person is key medicine particularly; Mend SUIGUBU kidney bone strengthening, continue and hinder pain relieving; The Radix Achyranthis Bidentatae invigorating the liver and kidney, bone and muscle strengthening, promoting blood circulation to restore menstrual flow, ignite (blood) is descending, inducing diuresis for treating stranguria syndrome; The Cortex cercis chinensis promoting blood circulation to restore menstrual flow, subduing swelling and detoxicating; The Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening, blood circulation regulating, continuous folding is hindered, and ends metrorrhagia.
The present invention fill a prescription promoting the circulation of blood, removing blood stasis with potent drugs, detumescence, pain relieving, dispel the wind, dampness, warming the meridian and promoting blood circulation, the evacuation of pus of eliminating the phlegm, expectorant saliva, the loose hypochondriac lump, clearing away heat-fire, the poison that detoxifies, purges heat, removing mass band, clots absorbing blood, expelling wind and removing dampness, dispel the wind, cold expelling, subduing inflammation.Because the present invention includes Flos Carthami, Radix Glycyrrhizae etc. thirties flavor medical materials, pharmacy is chronic, by the fermentation flow process, the property of medicine of medical material is fully caused, the penetration of medicine is strengthened; And the present invention cooperates the alcohol-pickled of rice wine, and ethanol itself can be used as guiding drug and causes drug effect; Immersion cooperates ointment to use again through medicinal liquid with the medicine gauze, also is further to have strengthened drug effect, has shortened treatment time, makes the property of medicine of ointment fully obtain performance.User is significant reaction in use, and medicine remarkably productive through reasonably using, can be abolished disease, thoroughly effects a radical cure sufferer.
In a word, application compress provided by the invention by the skin surface administration, make medicine see through each layer of skin, enter the body circulation and the generation therapeutical effect.
The specific embodiment
1, prescription:
Embodiment 1:
The present invention has disclosed a kind of prostatitic application compress for the treatment of, and it is comprised of first group of crude drug and second group of crude drug;
Described first group of crude drug comprises the crude drug of following weight portion: 10 parts of Ramulus Cinnamomi, 5 parts in Radix Glycyrrhizae, 10 parts in Radix Rehmanniae Preparata, 8 parts on Flos Carthami, 10 parts of Rhizoma Chuanxiong, 18 parts of Radix Angelicae Sinensis, 12 parts of Radix Paeoniae Rubra, 10 parts of the Cortexs Eucommiae, 20 parts of Caulis Clematidis Finetianaes, 10 parts of GUIGENG, 15 parts of Lignum Sappans, 15 parts of Cortex Cinnamomis, 15 parts of Fructus Psoraleaes, 10 parts of Semen Cuscutae, 15 parts of the Radixs Angelicae Dahuricae;
Described second group of crude drug comprises the crude drug of following weight portion: 10 parts of Cortex Phellodendris, 8 parts of Radix Notoginseng, 20 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 20 parts of Fructus Chaenomeliss, 8 parts of Pyritums, 10 parts of Rhizoma Drynariae, 10 parts of Radix Achyranthis Bidentataes, 20 parts of Cortex cercis chinensiss, 20 parts of Fructus Aurantiis, 10 parts of Cortex Cinnamomis, 15 parts in Radix Rehmanniae Preparata, 15 parts of Fructus Psoraleaes, 10 parts of Semen Cuscutae, 10 parts of Radix Dipsacis, 8 parts of Radix Clematidis.
The effect of this embodiment 1 prescription lays particular emphasis on antiinflammatory.
Embodiment 2:
The present invention has disclosed a kind of prostatitic application compress for the treatment of, and it is comprised of first group of crude drug and second group of crude drug;
Described first group of crude drug comprises the crude drug of following weight portion: 12 parts of Ramulus Cinnamomi, 8 parts in Radix Glycyrrhizae, 12 parts in Radix Rehmanniae Preparata, 10 parts on Flos Carthami, 12 parts of Rhizoma Chuanxiong, 20 parts of Radix Angelicae Sinensis, 15 parts of Radix Paeoniae Rubra, 12 parts of the Cortexs Eucommiae, 22 parts of Caulis Clematidis Finetianaes, 12 parts of GUIGENG, 20 parts of Lignum Sappans, 18 parts of Cortex Cinnamomis, 22 parts of Fructus Psoraleaes, 12 parts of Semen Cuscutae, 18 parts of the Radixs Angelicae Dahuricae;
Described second group of crude drug comprises the crude drug of following weight portion: 12 parts of Cortex Phellodendris, 12 parts of Radix Notoginseng, 22 parts of Radix Angelicae Sinensis, 12 parts on Flos Carthami, 25 parts of Fructus Chaenomeliss, 10 parts of Pyritums, 12 parts of Rhizoma Drynariae, 12 parts of Radix Achyranthis Bidentataes, 25 parts of Cortex cercis chinensiss, 25 parts of Fructus Aurantiis, 12 parts of Cortex Cinnamomis, 18 parts in Radix Rehmanniae Preparata, 18 parts of Fructus Psoraleaes, 12 parts of Semen Cuscutae, 12 parts of Radix Dipsacis, 10 parts of Radix Clematidis.
The effect of these embodiment 2 prescriptions lays particular emphasis on blood stasis dispelling.
Embodiment 3
The present invention has disclosed a kind of prostatitic application compress for the treatment of, and it is comprised of first group of crude drug and second group of crude drug;
Described first group of crude drug comprises the crude drug of following weight portion: 15 parts of Ramulus Cinnamomi, 15 parts in Radix Glycyrrhizae, 20 parts in Radix Rehmanniae Preparata, 15 parts on Flos Carthami, 15 parts of Rhizoma Chuanxiong, 25 parts of Radix Angelicae Sinensis, 20 parts of Radix Paeoniae Rubra, 15 parts of the Cortexs Eucommiae, 25 parts of Caulis Clematidis Finetianaes, 20 parts of GUIGENG, 30 parts of Lignum Sappans, 20 parts of Cortex Cinnamomis, 25 parts of Fructus Psoraleaes, 15 parts of Semen Cuscutae, 20 parts of the Radixs Angelicae Dahuricae;
Described second group of crude drug comprises the crude drug of following weight portion: 15 parts of Cortex Phellodendris, 15 parts of Radix Notoginseng, 25 parts of Radix Angelicae Sinensis, 15 parts on Flos Carthami, 30 parts of Fructus Chaenomeliss, 15 parts of Pyritums, 15 parts of Rhizoma Drynariae, 15 parts of Radix Achyranthis Bidentataes, 30 parts of Cortex cercis chinensiss, 30 parts of Fructus Aurantiis, 15 parts of Cortex Cinnamomis, 20 parts in Radix Rehmanniae Preparata, 20 parts of Fructus Psoraleaes, 15 parts of Semen Cuscutae, 15 parts of Radix Dipsacis, 15 parts of Radix Clematidis.
The effect of these embodiment 2 prescriptions lays particular emphasis on pain relieving.
2, preparation method:
Above-mentioned a kind of preparation method for the treatment of the prostatitis application compress, it may further comprise the steps:
Step 1, get first group of crude drug, with first group of crude drug with fermenting after rice wine mixes by the 1:8-12 weight ratio, more than fermentation half a year, obtain first group of raw material medicinal liquid;
Step 2, first group of raw material medicinal liquid after step 1 fermentation filtered, obtain first group of crude drug filtrate;
Step 3, first group of crude drug filtrate getting 85%-95% add second group of crude drug, first group of crude drug filtrate mixes by the weight ratio of 1:9-16 with second group of crude drug, fermentation 5-15 day, presents the mud shape, add binding agent and carry out adhesive formulations, make ointment;
Step 4, the hospital gauze of well cutting is put into the remaining first group of crude drug filtrate of step 2 soak, soak and 8-12 day make absorbent gauze.
The fermentation temperature of described step 1 is 40-50 ℃.
Binding agent in the described step 3 is dextrin or Fructus Hordei Germinatus.
3, using method:
Above-mentioned a kind of using method for the treatment of the prostatitis application compress, it may further comprise the steps:
Step 1, get the absorbent gauze that soaks, spread ointment, be used for umbilicus and lower abdomen place, and to carrying out 35-45 ℃ heated at constant temperature herein, once a day, every next hour.
4, curative effect:
Case:
1, Tongan principal Jiang got prostatic hyperplasia in the time of 86 years old, the hospital doctor inspection need to be had an operation, and he is unwilling to have an operation, and through two first quarter moons of external application for curing, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
2, the Mr. Liu of Fujian Province capital construction commission, 58 years old, got the prostate weight gaining large, prostatitis, can't fall asleep evening, a night 6-7 urine, tire out daytime, inefficent inefficiency.Process external application for curing three months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
3, Xiamen Mr. Zhang, 63 years old, the examination in hospital prostatitis, urinary obstruction is smooth, and the time is long, urine retention, get up 4-5 evening, and impact is had a rest, mental fatigue.Process external application for curing two months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
3, Xiamen Mr. Chen, 59 years old, examination in hospital, prostatitis, hypertrophy has been eaten Western medicine and Chinese medicine, has seen a lot of experts, does not have remarkable result, and average one hour of evening got up once, sometimes had the urine meaning but can not urinate.Process external application for curing two months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
4, Xiamen Mr. Luo, 56 years old, urinary obstruction was smooth, urine retention, urination time is long, and get up in the night to urinate 4-5 evening, do not have spirit daytime.Process external application for curing one month, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
5, Quanzhou Mr. Li, 43 years old, the row adenitis, hypertrophy, get up 5-6 evening, sometimes has the urine meaning but can not urinate, the once in a while pain of urinating.Process external application for curing two months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
6, ZhangZhou Mr. Wu, 60 years old, urinary obstruction was smooth, urine retention, urodynia, urination time is long, and get up in the night to urinate 4-5 evening, do not have spirit daytime.Through the external application for curing one and a half months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
7, Quanzhou Mr. Liu, 78 years old, got the prostate weight gaining large, prostatitis, can't fall asleep evening, a night 4-5 urine, tire out daytime.Through the external application for curing one and a half months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
8, Xiamen Mr. Li, 55 years old, the examination in hospital prostatitis, hypertrophy, urinary obstruction is smooth, and the time is long, and urine retention is got up in the night to urinate repeatedly evening, and impact is had a rest, and the mental fatigue duty is poor.Through the external application for curing one and a half months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
9, Foochow Mr. Chen, 39, examination in hospital, prostatitis, repeatedly get up in the night to urinate evening, sometimes has the urine meaning but can not urinate.Process external application for curing one month, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
10, Foochow Mr. Tang, 53 years old, urinary obstruction was smooth, urine retention, urination time is long, and get up in the night to urinate 4-5 evening, do not have spirit daytime.Through the external application for curing one and a half months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
11, Nan Ping Mr. Lv, 67 years old, the row adenitis, hypertrophy, get up 5-6 evening, sometimes has the urine meaning but can not urinate, the once in a while pain of urinating.Process external application for curing two months, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
12, Quanzhou Mr. Ceng, 50 years old, urinary obstruction was smooth, urine retention, urodynia, urination time is long, and get up in the night to urinate 4-5 evening, do not have spirit daytime.Through two first quarter moons of external application for curing, when checking to hospital, through diagnosis, disease disappears, and has fully recovered.
Claims (5)
1. the prostatitic application compress for the treatment of is characterized in that: be comprised of first group of crude drug and second group of crude drug;
Described first group of crude drug comprises the crude drug of following weight portion: Ramulus Cinnamomi 10-15 part, Radix Glycyrrhizae 5-15 part, Radix Rehmanniae Preparata 15-20 part, Flos Carthami 8-15 part, Rhizoma Chuanxiong 10-15 part, Radix Angelicae Sinensis 18-25 part, Radix Paeoniae Rubra 12-20 part, Cortex Eucommiae 10-15 part, Caulis Clematidis Finetianae 20-25 part, GUIGENG 10-20 part, Lignum Sappan 15-30 part, Cortex Cinnamomi 15-20 part, Fructus Psoraleae 15-25 part, Semen Cuscutae 10-15 part, Radix Angelicae Dahuricae 15-20 part;
Described second group of crude drug comprises the crude drug of following weight portion: Cortex Phellodendri 10-15 part, Radix Notoginseng 8-15 part, Radix Angelicae Sinensis 20-25 part, Flos Carthami 10-15 part, Fructus Chaenomelis 20-30 part, Pyritum 8-15 part, Rhizoma Drynariae 10-15 part, Radix Achyranthis Bidentatae 10-15 part, Cortex cercis chinensis 20-30 part, Fructus Aurantii 20-30 part, Cortex Cinnamomi 10-15 part, Radix Rehmanniae Preparata 15-20 part, Fructus Psoraleae 15-20 part, Semen Cuscutae 10-15 part, Radix Dipsaci 10-15 part, Radix Clematidis 8-15 part.
2. the preparation method for the treatment of prostatitis application compress as claimed in claim 1, it is characterized in that: it may further comprise the steps:
Step 1, get first group of crude drug, with first group of crude drug with ferment after rice wine mixes by the 1:8-12 weight ratio, more than fermentation half a year, obtain first group of raw material medicinal liquid;
Step 2, first group of raw material medicinal liquid after step 1 fermentation filtered, obtain first group of crude drug filtrate;
Step 3, first group of crude drug filtrate getting 85%-95% add second group of crude drug, first group of crude drug filtrate mixes by the weight ratio of 1:9-16 with second group of crude drug, fermentation 5-15 day, presents the mud shape, add binding agent and carry out adhesive formulations, make ointment;
Step 4, the hospital gauze of well cutting is put into the remaining first group of crude drug filtrate of step 2 soak, soak and 8-12 day make absorbent gauze.
3. the preparation method for the treatment of prostatitis application compress as claimed in claim 1, it is characterized in that: the fermentation temperature of described step 1 is 40-50 ℃.
4. the preparation method for the treatment of prostatitis application compress as claimed in claim 1, it is characterized in that: the binding agent in the described step 3 is dextrin or Fructus Hordei Germinatus.
5. the using method for the treatment of prostatitis application compress as claimed in claim 1 is characterized in that: gets the absorbent gauze that soaks, spreads ointment, be used for umbilicus and lower abdomen place, and to carrying out 35-45 ℃ heated at constant temperature herein, once a day, every next hour.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210435474 CN102920833A (en) | 2012-11-05 | 2012-11-05 | Externally applied medicine for curing prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210435474 CN102920833A (en) | 2012-11-05 | 2012-11-05 | Externally applied medicine for curing prostatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102920833A true CN102920833A (en) | 2013-02-13 |
Family
ID=47635858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210435474 Pending CN102920833A (en) | 2012-11-05 | 2012-11-05 | Externally applied medicine for curing prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102920833A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705872A (en) * | 2014-01-10 | 2014-04-09 | 刘海宏 | Externally-applied traditional Chinese medicine for treating prostatic diseases |
CN103860894A (en) * | 2014-04-02 | 2014-06-18 | 宋玉明 | Medicament for treating chronic prostatitis |
CN105795782A (en) * | 2014-12-29 | 2016-07-27 | 项小飞 | Chronic prostatitis health care cushion |
-
2012
- 2012-11-05 CN CN 201210435474 patent/CN102920833A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705872A (en) * | 2014-01-10 | 2014-04-09 | 刘海宏 | Externally-applied traditional Chinese medicine for treating prostatic diseases |
CN103705872B (en) * | 2014-01-10 | 2016-03-30 | 刘海宏 | A kind of Traditional Chinese Medicine for external application for the treatment of prostatosis |
CN103860894A (en) * | 2014-04-02 | 2014-06-18 | 宋玉明 | Medicament for treating chronic prostatitis |
CN103860894B (en) * | 2014-04-02 | 2016-03-09 | 宋玉明 | A kind of medicine for the treatment of chronic prostatitis |
CN105795782A (en) * | 2014-12-29 | 2016-07-27 | 项小飞 | Chronic prostatitis health care cushion |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
CN109966413A (en) | It is a kind of for treating the traditional Chinese medicine for external application of the peripheral neuropathy of caused by chemotherapeutic medicines | |
CN102920833A (en) | Externally applied medicine for curing prostatitis | |
CN101007040A (en) | External applied medicine for treating fractures | |
CN1326550C (en) | Quick acting analgetic Chinese medicine liquid | |
CN1325110C (en) | Medicated wine for treating traumatic injury | |
CN101417003A (en) | Traditional Chinese medicine composition for treating vertebras disease | |
CN1478526A (en) | Pure medicinal liquor | |
CN102961483A (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
CN102935185B (en) | Pills for treating neurasthenia and preparation method | |
CN102600343A (en) | Chinese medicinal preparation for treating oral diseases and/or toothache | |
CN102389469A (en) | Foot bathing health care medicament | |
CN101129630B (en) | Medicament for treating rheumatism, arthritis pauperum | |
CN102380044A (en) | Oral medicament for traditional Chinese medicine treatment of cervical spondylosis | |
CN101342344A (en) | Chinese medicine for treating piles | |
CN104208550A (en) | Traditional Chinese medicine composition used for treatment of kidney-yang deficiency type enuresis disease of old people | |
CN104189661A (en) | Traditional Chinese medicine for treating fibromyalgia syndrome | |
CN107998367A (en) | A kind of dispersing swelling and dissipating binds stasis-dispelling and pain-killing plaster | |
CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
CN107137649A (en) | A kind of instant particles as Chinese medicine and preparation method for treating Female Urethral Syndrome | |
CN101288760B (en) | Externally-used drug for treating appendicitis | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
CN105412698A (en) | Traditional Chinese medicine composition for treating chronic prostatitis and preparation process thereof | |
CN105521391A (en) | Traditional Chinese medicine for tonifying liver and kidney and for strengthening bones and muscles and preparation method of traditional Chinese medicine | |
CN104147312A (en) | Traditional Chinese medicine preparation for treating male infertility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130213 |